Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Nuclear Medicine and Biology|March 9, 2000
Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumorsE T Janson, K M Kälkner, B Eriksson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?T Jansson, J E Westlin, H Ahlström, et al.Anticancer Research|March 1, 1997
Biological characteristics of adrenocortical carcinoma: a study of p53, IGF, EGF-r, Ki-67 and PCNA in 17 adrenocortical carcinomasM Edgren, B Eriksson, E Wilander, et al.European Journal of Endocrinology|December 1, 1994
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatmentE T Janson, J E Westlin, B Eriksson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Ion exchange tumor targeting: a new approachA R Holmberg, M Wilchek, M Márquez, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotideJ E Westlin, E T Janson, H Arnberg, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effectsM Edgren, J E Westlin, H Letocha, et al.Anticancer Research|August 23, 2000
Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinoma and immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibodyG Ljung, B Lennernäs, H Nordgren, et al.British Journal of Urology|December 1, 1994
Positron emission tomography with L-methyl-11C-methionine in the monitoring of therapy response in muscle-invasive transitional cell carcinoma of the urinary bladderH Letocha, H Ahlström, P U Malmström, et al.Nordisk Medicin|December 4, 1998
[PET in neuroendocrine tumors]B Eriksson, H Orlefors, A Sundin, et al.Pageof 6